Comparison of HbA1c, Uric Acid/HDL-C ratio, and Electroneuromyography (ENMG) results in patients with Type 2 Diabetes Mellitus
Abstract views: 117
/ 
PDF downloads: 48
DOI:
https://doi.org/10.26900/hsq.2845Keywords:
Uric acid HDL, ratio, HbA1c, diabetic polyneuropathyAbstract
This study aims to compare the uric acid/HDL-C ratio and electroneuromyography (ENMG) results in patients with type 2 diabetes mellitus (T2DM) and to investigate whether these parameters differ in the presence or absence of diabetic peripheral neuropathy (DPN). Additionally, it evaluates the potential of HbA1c and the uric acid/HDL-C ratio as biomarkers for diagnosing DPN. This study was carried out retrospectively in the Neurology Clinic of Gaziantep City Hospital. The participants included 50 T2DM patients diagnosed with DPN through ENMG, 50 Type 2 DM patients without DPN, and 50 healthy controls. Demographic data, biochemical parameters (uric acid, HDL cholesterol, HbA1c), and ENMG results were analyzed. Intergroup comparisons and correlation analyses were performed. No significant differences in the uric acid/HDL-C ratio were observed among T2DM patients with DPN, those without DPN, and healthy controls. Moreover, the correlation between the uric acid/HDL-C ratio and ENMG results was found to be limited. The present study does not support the use of the uric acid/HDL-C ratio for neuropathy diagnosis, indicating the need for further research.
Downloads
References
Tesfaye S, Selvarajah D. Diabetic peripheral neuropathy: Explanatory factors and clinical relevance. Diabetes Res Clin Pract. 2012;96(3):214-23. doi: 10.1016/j.diabres.2011.12.013. DOI: https://doi.org/10.1016/j.diabres.2011.12.013
Kosekli MA, Aktas G. Serum uric acid to HDL cholesterol ratio is associated with diabetic control in new onset type 2 diabetic population. Acta Clin Croat. 2023;62(2):277-82. doi: 10.20471/acc.2023.62.02.14. DOI: https://doi.org/10.20471/acc.2023.62.02.14
Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2016;31(6):890-6. doi: 10.1093/ndt/gfv050. DOI: https://doi.org/10.1093/ndt/gfv024
Shi Y, Chen W, Jalal D, Li Z, Chen W, Mao H, et al. Clinical outcome of hyperuricemia in IgA nephropathy: A retrospective cohort study and randomized controlled trial. Kidney Blood Press Res. 2012;35(3):153-60. doi: 10.1159/000331453. DOI: https://doi.org/10.1159/000331453
Cheng Y, Zhang H, Zheng H, Yin H, Wang Y, Wang H, et al. Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: A cross-sectional study based on a health check-up population. BMJ Open. 2022;12(12):e066243. doi: 10.1136/bmjopen-2022-066243. DOI: https://doi.org/10.1136/bmjopen-2022-066243
Han X, Tan X, Liu M, Wei Y, He A, Pan Y, et al. Association between serum uric acid/high-density lipoprotein cholesterol ratio and hypertension among reproductive-aged women. J Health Popul Nutr. 2023;42(1):123. doi: 10.1186/s41043-023-00472-3. DOI: https://doi.org/10.1186/s41043-023-00458-3
Xuan Y, Zhang W, Wang Y, Wang B, Xia F, Zhang K, et al. Association between uric acid to HDL cholesterol ratio and diabetic complications in men and postmenopausal women. Diabetes Metab Syndr Obes. 2023;16:167-77. doi: 10.2147/DMSO.S387726. DOI: https://doi.org/10.2147/DMSO.S387726
She D, Xu W, Liu J, Zhang Z, Fang P, Li R, et al. Serum uric acid to creatinine ratio and risk of metabolic syndrome in patients with overweight/obesity. Diabetes Metab Syndr Obes. 2023;16:3007-17. doi: 10.2147/DMSO.S418689. DOI: https://doi.org/10.2147/DMSO.S427070
Uzeli U, Doğan AG. The relationship between diabetic neuropathy and uric acid/high-density lipoprotein ratio in patients with type 2 diabetes mellitus. Cureus. 2023;15(9):e45151. doi: 10.7759/cureus.45151. DOI: https://doi.org/10.7759/cureus.45151
Zhen R, Wang S, Chen S. The relationship between UA/HDL and diabetic peripheral neuropathy: A cross-sectional analysis. Diabetes Metab Syndr Obes. 2024;17:969-80. doi: 10.2147/DMSO.S447809. DOI: https://doi.org/10.2147/DMSO.S447809
S Singh R, Sharma S, Kaur P. Diabetic neuropathy: An update on its clinical significance. J Diabetes Res. 2014;2014:654193. doi: 10.1155/2014/654193. DOI: https://doi.org/10.1155/2014/654193
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-54. doi: 10.2337/dc16-2042. DOI: https://doi.org/10.2337/dc16-2042
Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Diabetic neuropathy: An update on protein kinase C activation and targets for therapy. Diabetes Care. 2009;32(7):1476-82. doi: 10.2337/dc08-2174. DOI: https://doi.org/10.2337/dc08-2174
Vincent A, Sussex E, Hutton M, Unwin N, Alberti KG. Diabetes-related neuropathies: Epidemiology and treatment. BMJ. 2009;339:b393. doi: 10.1136/bmj.b393. DOI: https://doi.org/10.1136/bmj.b393
Joosten LAB, Crisan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricemia: A silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75-86. doi: 10.1038/s41584-019-0334-3. DOI: https://doi.org/10.1038/s41584-019-0334-3
Miao Y, Ottenbros SA, Laverman GD, Brenner BM, Cooper ME, Parving HH, et al. Effect of a reduction in uric acid on renal outcomes during losartan treatment: A post hoc analysis of the RENAAL trial. Hypertension. 2011;58(1):2-7. doi: 10.1161/HYPERTENSIONAHA.111.171488. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.111.171488
Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729-41. doi: 10.1097/HJH.0000000000000701. DOI: https://doi.org/10.1097/HJH.0000000000000701
Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced peripheral nervous system repair in diabetic neuropathy using phosphoinositide 3-kinase/Akt signaling. Diabetes Care. 2012;35(7):1374-80. doi: 10.2337/dc11-2202. DOI: https://doi.org/10.1002/14651858.CD007543.pub2
Feldman EL. Oxidative stress and diabetic neuropathy: A new understanding of an old problem. J Clin Invest. 2003;111(4):431-3. doi: 10.1172/JCI17862. DOI: https://doi.org/10.1172/JCI17862
Liu Z, Hu Y, Chen J, Wang J, Zhou Y, Tang J, et al. Role of chronic inflammation in diabetic neuropathy. Diabetes Obes Metab. 2019;21(4):927-36. doi: 10.1111/dom.13607. DOI: https://doi.org/10.1111/dom.13607
Fayazi HS, Faramarzi M, Pakzad R, Rezaei N. The relation between serum uric acid levels and diabetic peripheral neuropathy. BMC Endocr Disord. 2022;22:53. doi: 10.1186/s12902-022-00952-5. DOI: https://doi.org/10.1186/s12902-022-00952-5
Bazmandegan G, Dehghani MH, Karimifard M, Kahnooji M, Balaee P, Zakeri MA, et al. Uric acid to HDL ratio: A marker for predicting incidence of metabolic syndrome in patients with type II diabetes. Nutr Metab Cardiovasc Dis. 2024;34(4):1014-20. doi: 10.1016/j.numecd.2023.12.022. DOI: https://doi.org/10.1016/j.numecd.2023.12.022
Balci SB, Atak BM, Duman T, Ozkul FN, Aktas G. A novel marker for prediabetic conditions: Uric acid-to-HDL cholesterol ratio. Bratisl Lek Listy. 2024;125(3):145-8. doi: 10.4149/BLL_2023_130. DOI: https://doi.org/10.4149/BLL_2023_130
Cascio MA, Mukhdomi T. Small fiber neuropathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. PMID:35881752. Available from: https://pubmed.ncbi.nlm.nih.gov/35881752/. (Accessed on Sep 13, 2025).
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. doi: 10.1038/s41572-019-0092-1. DOI: https://doi.org/10.1038/s41572-019-0092-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Holistence Publications
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Everyone who is listed as an author in this article should have made a substantial, direct, intellectual contribution to the work and should take public responsibility for it.
